Demographic Data
| Method | Participant | Sex | Indication | Age (y) | Body mass index | Administered activity (MBq) | Injection time* | Whole-body imaging time* | Percentage estimated effective dose increase | Imaging findings according to indication |
| Cyclotron | C1 | F | Bilateral thyroid nodule | 45 | 28.0 | 296.8 | 5:03 | 6:34 | Hypothyroidism | |
| C2 | F | Hyperthyroidism, Graves disease | 49 | 31.3 | 351.5 | 6:31 | 7:29 | 1.04 | Graves disease | |
| C3 | F | Multinodular goiter | 77 | 25.0 | 291.4 | 5:48 | 7:32 | 1.20 | Subclinical hyperthyroidism | |
| C4 | F | Hypothyroidism | 34 | 19.4 | 351.0 | 5:36 | 6:34 | 0.94 | Thyroiditis | |
| C5 | F | Hyperthyroidism | 28 | 17.2 | 353.3 | 6:49 | 7:52 | 1.15 | Thyroiditis, goiter? | |
| C6 | M | Nodules | 60 | 22.7 | 329.9 | 4:54 | 6:13 | 1.54 | Multinodular goiter | |
| C7 | F | Graves disease | 19 | 25.5 | 270.7 | 6:07 | 7:04 | 1.75 | Graves disease | |
| C8 | M | Hyperthyroidism de novo | 65 | 27.6 | 330.2 | 4:40 | 6:03 | 1.60 | Thyroiditis | |
| C9 | F | Hyperthyroidism | 47 | 35.8 | 308.6 | 6:41 | 7:32 | 1.98 | Graves disease | |
| C10 | F | Thyroiditis or hyperthyroidism | 32 | 34.1 | 347.7 | 5:35 | 6:13 | 1.76 | Thyroiditis | |
| C11 | M | Hyperthyroidism | 36 | 22.6 | 348.4 | 7:03 | 9:00 | 1.93 | Graves disease | |
| Generator | G1 | F | Nodule | 34 | 39.8 | 345.6 | NA | NA | NA | Nonfunctional nodule formation |
| G2 | M | Hyperthyroidism | 66 | 21.1 | 346.5 | NA | NA | NA | Thyroiditis | |
| G3 | F | Goiter, Graves disease | 31 | 24.2 | 341.7 | NA | NA | NA | Subclinical hyperthyroidism, suspected thyroid nodule | |
| G4 | F | Nodules | 47 | 19.7 | 340.0 | NA | NA | NA | Subclinical hyperthyroidism, hyperfunctional nodules | |
| G5 | F | Hyperthyroidism | 28 | 18.3 | 349.5 | NA | NA | NA | Graves disease | |
| G6 | F | Nodules | 50 | 16.2 | 334.6 | NA | NA | NA | Multinodular goiter | |
| G7 | M | Nodule | 59 | 27.2 | 345.1 | NA | NA | NA | Nonfunctional thyroid nodule | |
| G8 | F | Hyperthyroidism | 35 | 35.3 | 336.0 | NA | NA | NA | Graves disease, suspected nonfunctional nodule |
↵* Hours after EOB.
NA = not applicable.